ArticlePloS one2023

Preclinical evaluation of Insulin-like growth factor receptor 1 (IGF1R) and Insulin Receptor (IR) as a therapeutic targets in triple negative breast cancer.

Sandra Roche et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.